Cargando…

A New Direction for Closed-Loop Spinal Cord Stimulation: Combining Contemporary Therapy Paradigms with Evoked Compound Action Potential Sensing

Spinal cord stimulation (SCS) utilizes the delivery of mild electrical pulses via epidural electrodes placed on the dorsal side of the spinal cord, typically to treat chronic pain. The first clinical use of SCS involved the delivery of paresthesia inducing, low-frequency waveforms to the neural targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallejo, Ricardo, Chakravarthy, Krishnan, Will, Andrew, Trutnau, Karen, Dinsmoor, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721159/
https://www.ncbi.nlm.nih.gov/pubmed/35002310
http://dx.doi.org/10.2147/JPR.S344568
_version_ 1784625277183197184
author Vallejo, Ricardo
Chakravarthy, Krishnan
Will, Andrew
Trutnau, Karen
Dinsmoor, David
author_facet Vallejo, Ricardo
Chakravarthy, Krishnan
Will, Andrew
Trutnau, Karen
Dinsmoor, David
author_sort Vallejo, Ricardo
collection PubMed
description Spinal cord stimulation (SCS) utilizes the delivery of mild electrical pulses via epidural electrodes placed on the dorsal side of the spinal cord, typically to treat chronic pain. The first clinical use of SCS involved the delivery of paresthesia inducing, low-frequency waveforms to the neural targets corresponding to the painful areas. Contemporary SCS therapies now leverage novel therapeutic pathways to limit paresthesia and deliver superior clinical outcomes. Historically, SCS has largely been delivered with fixed stimulation parameters. This approach, referred to as open-loop (OL) SCS, does not account for the fluctuations in spacing—driven by postural changes and activity—between the electrodes and the cord. These fluctuations result in variability in the delivered dose and the volume of tissue activation (VTA) that manifests with each stimulation pulse. Inconsistent dosing may lead to suboptimal therapeutic efficacy and durability. To address this clinical need, closed-loop (CL) SCS systems have been developed to automatically adjust stimulation parameters to compensate for this variability. The evoked compound action potential (ECAP), a biopotential generated by the synchronous activation of dorsal column fibers, is indicative of the VTA resulting from the stimulation pulse. The ECAP may be utilized as a control signal in CL SCS systems to adjust stimulation parameters to reduce variability in the ECAP, and in turn, variability in the VTA. While investigational CL SCS systems with ECAP sensing have so far focused solely on managing paresthesia-based SCS, such systems must also incorporate the stimulation approaches that now define the contemporary clinical practice of SCS. Accordingly, we describe here a flexible, next-generation framework for neural responsive SCS that blends science-based methodologies for pain management with real-time CL control for biophysical variation. We conclude with a clinical example of such a system and the associated performance characteristics.
format Online
Article
Text
id pubmed-8721159
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87211592022-01-06 A New Direction for Closed-Loop Spinal Cord Stimulation: Combining Contemporary Therapy Paradigms with Evoked Compound Action Potential Sensing Vallejo, Ricardo Chakravarthy, Krishnan Will, Andrew Trutnau, Karen Dinsmoor, David J Pain Res Perspectives Spinal cord stimulation (SCS) utilizes the delivery of mild electrical pulses via epidural electrodes placed on the dorsal side of the spinal cord, typically to treat chronic pain. The first clinical use of SCS involved the delivery of paresthesia inducing, low-frequency waveforms to the neural targets corresponding to the painful areas. Contemporary SCS therapies now leverage novel therapeutic pathways to limit paresthesia and deliver superior clinical outcomes. Historically, SCS has largely been delivered with fixed stimulation parameters. This approach, referred to as open-loop (OL) SCS, does not account for the fluctuations in spacing—driven by postural changes and activity—between the electrodes and the cord. These fluctuations result in variability in the delivered dose and the volume of tissue activation (VTA) that manifests with each stimulation pulse. Inconsistent dosing may lead to suboptimal therapeutic efficacy and durability. To address this clinical need, closed-loop (CL) SCS systems have been developed to automatically adjust stimulation parameters to compensate for this variability. The evoked compound action potential (ECAP), a biopotential generated by the synchronous activation of dorsal column fibers, is indicative of the VTA resulting from the stimulation pulse. The ECAP may be utilized as a control signal in CL SCS systems to adjust stimulation parameters to reduce variability in the ECAP, and in turn, variability in the VTA. While investigational CL SCS systems with ECAP sensing have so far focused solely on managing paresthesia-based SCS, such systems must also incorporate the stimulation approaches that now define the contemporary clinical practice of SCS. Accordingly, we describe here a flexible, next-generation framework for neural responsive SCS that blends science-based methodologies for pain management with real-time CL control for biophysical variation. We conclude with a clinical example of such a system and the associated performance characteristics. Dove 2021-12-29 /pmc/articles/PMC8721159/ /pubmed/35002310 http://dx.doi.org/10.2147/JPR.S344568 Text en © 2021 Vallejo et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Perspectives
Vallejo, Ricardo
Chakravarthy, Krishnan
Will, Andrew
Trutnau, Karen
Dinsmoor, David
A New Direction for Closed-Loop Spinal Cord Stimulation: Combining Contemporary Therapy Paradigms with Evoked Compound Action Potential Sensing
title A New Direction for Closed-Loop Spinal Cord Stimulation: Combining Contemporary Therapy Paradigms with Evoked Compound Action Potential Sensing
title_full A New Direction for Closed-Loop Spinal Cord Stimulation: Combining Contemporary Therapy Paradigms with Evoked Compound Action Potential Sensing
title_fullStr A New Direction for Closed-Loop Spinal Cord Stimulation: Combining Contemporary Therapy Paradigms with Evoked Compound Action Potential Sensing
title_full_unstemmed A New Direction for Closed-Loop Spinal Cord Stimulation: Combining Contemporary Therapy Paradigms with Evoked Compound Action Potential Sensing
title_short A New Direction for Closed-Loop Spinal Cord Stimulation: Combining Contemporary Therapy Paradigms with Evoked Compound Action Potential Sensing
title_sort new direction for closed-loop spinal cord stimulation: combining contemporary therapy paradigms with evoked compound action potential sensing
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721159/
https://www.ncbi.nlm.nih.gov/pubmed/35002310
http://dx.doi.org/10.2147/JPR.S344568
work_keys_str_mv AT vallejoricardo anewdirectionforclosedloopspinalcordstimulationcombiningcontemporarytherapyparadigmswithevokedcompoundactionpotentialsensing
AT chakravarthykrishnan anewdirectionforclosedloopspinalcordstimulationcombiningcontemporarytherapyparadigmswithevokedcompoundactionpotentialsensing
AT willandrew anewdirectionforclosedloopspinalcordstimulationcombiningcontemporarytherapyparadigmswithevokedcompoundactionpotentialsensing
AT trutnaukaren anewdirectionforclosedloopspinalcordstimulationcombiningcontemporarytherapyparadigmswithevokedcompoundactionpotentialsensing
AT dinsmoordavid anewdirectionforclosedloopspinalcordstimulationcombiningcontemporarytherapyparadigmswithevokedcompoundactionpotentialsensing
AT vallejoricardo newdirectionforclosedloopspinalcordstimulationcombiningcontemporarytherapyparadigmswithevokedcompoundactionpotentialsensing
AT chakravarthykrishnan newdirectionforclosedloopspinalcordstimulationcombiningcontemporarytherapyparadigmswithevokedcompoundactionpotentialsensing
AT willandrew newdirectionforclosedloopspinalcordstimulationcombiningcontemporarytherapyparadigmswithevokedcompoundactionpotentialsensing
AT trutnaukaren newdirectionforclosedloopspinalcordstimulationcombiningcontemporarytherapyparadigmswithevokedcompoundactionpotentialsensing
AT dinsmoordavid newdirectionforclosedloopspinalcordstimulationcombiningcontemporarytherapyparadigmswithevokedcompoundactionpotentialsensing